(Q53358511)

13 May 2018

title

Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. (English)

1 reference

13 May 2018

main subject

uterine cervix neoplasm

1 reference

Jung Yeon Kim

1

1 reference

13 May 2018

Sung Jig Lim

2

1 reference

13 May 2018

Kyeongmee Park

3

1 reference

13 May 2018

Chul-Min Lee

4

1 reference

13 May 2018

Juree Kim

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

13 May 2018

published in

Gynecologic Oncology

1 reference

13 May 2018

volume

97

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

337-341

1 reference

13 May 2018

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Frequent amplification of C-erbB2 (HER-2/Neu) oncogene in cervical carcinoma as detected by non-fluorescence in situ hybridization technique on paraffin sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Validation of tissue microarray technology in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

C-erbB-2 [correction of C-erB] in cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Topoisomerase II-alpha (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Cyclooxygenase-2 and c-erbB-2 expression in colorectal carcinoma assessed using tissue microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

High cyclooxygenase-2 expression in cervical adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.09.012

10.1016/J.YGYNO.2004.09.012

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

release_p3firg2e3rarbes64jjf2iwlii

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p3firg2e3rarbes64jjf2iwlii

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 May 2018